Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
/CORRECTION/ -- NapaJen Pharma, Inc./ 2019-01-09 21:52
NapaJen Pharma Closes $12.4 Million Series C Financing 2019-01-09 14:00
Adagene Announces Collaboration for Discovery of Novel CAR-T with the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) 2019-01-08 09:44
China Biologic Reiterates Full Year 2018 Financial Forecast 2019-01-07 21:00
Uni-Bio Science's Anti-diabetic Acarbose Oral Tablets BE Study Application Accepted by the National Medical Products Administration 2019-01-05 01:04
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology 2019-01-04 09:30
Adlai Nortye Announces Clinical Collaboration with Merck to Evaluate Adlai Nortye's AN0025 (EP4 Antagonist) in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors 2019-01-03 16:00
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering 2019-01-03 02:30
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company 2019-01-02 12:37
InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer 2018-12-29 03:33
MEDI FUTURES Raises US$5M Funding Led by Samho Green Investment 2018-12-28 21:00
Bridge Biotherapeutics Announces a Successful Activation of U.S. Clinical Trial Sites for BBT-401 Phase 2 Study 2018-12-28 07:00
China's NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin's Lymphoma 2018-12-27 16:45
Exosystems to Demo Gamified Physical Therapy Technology at CES 2019 2018-12-27 00:00
I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2 2018-12-24 11:45
HistoIndex's Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal's Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial 2018-12-23 17:00
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way 2018-12-21 17:50
Shanghai Concord Medical Cancer Center has completed the First Bill of Medical Insurance Settlement on 2018 December 17th 2018-12-20 17:41
Concord Medical Announces a Topping Out Ceremony of Guangzhou Concord Cancer Center 2018-12-19 17:29
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate 2018-12-19 08:00
1 218 219 220 221 222 421